About the Eye Lymphoma Session
Eye lymphoma, also known as ocular lymphoma, is a rare form of cancer that affects the lymphatic system in the eye. This type of lymphoma typically originates in the lymphocytes, a type of white blood cell, and can manifest in different parts of the eye, including the conjunctiva, iris, or retina. Research in eye lymphoma primarily focuses on understanding its pathogenesis, improving diagnostic techniques, and developing targeted therapies. Advances in imaging technologies such as optical coherence tomography (OCT) and molecular diagnostics have enhanced early detection and treatment monitoring. Additionally, novel treatment approaches including immunotherapy and targeted therapies tailored to specific genetic mutations are being explored to improve outcomes for patients with this challenging disease. Continued research efforts are crucial for advancing our understanding and management of eye lymphoma.
Topics Covered in Eye Lymphoma
Vitreoretinal Lymphoma
Adnexal MALT Lymphoma
Diagnostic Vitrectomy
Intravitreal Therapy
Ocular Radiotherapy
CNS Involvement
Related Scientific Sessions at CIOC 2027
Why Attend the Eye Lymphoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Eye Lymphoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Eye Lymphoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Eye Lymphoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Eye Lymphoma Conference 2027 — FAQs
What is the Eye Lymphoma track at CIOC 2027?
The Eye Lymphoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Eye Lymphoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Eye Lymphoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Eye Lymphoma are all welcome — whether presenting or attending.
Can I present my research in the Eye Lymphoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Eye Lymphoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Eye Lymphoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.